Retatrutide (development code LY3437943) is a synthetic 39-amino-acid peptide engineered to act as a triple agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors. Its multi-receptor design has made it one of the most closely followed compounds in current metabolic research.
Research Applications
Laboratory research with retatrutide focuses on incretin receptor signalling and selectivity assays, comparative studies against single- and dual-agonist peptides, energy expenditure and adipose tissue models, and glucose homeostasis research conducted in vitro and in animal models.
Product Specifications
- Quantity: 10mg per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Sequence length: 39 amino acids
- Molecular weight: ≈4731.3 Da
- Storage: Store at -20°C. Reconstituted solution stable at 2-8°C for up to 14 days.
- CAS Number: 2381089-83-2
⚠️ For laboratory and research use only. Not intended for human or veterinary use.
